Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent Biosolutions
(NY:
EBS
)
1.920
-0.030 (-1.54%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Emergent Biosolutions
< Previous
1
2
3
4
5
6
7
8
Next >
Emergent Secures Contract To Manufacture Providence Therapeutics' COVID-19 Vaccine Candidate
September 14, 2021
Emergent BioSolutions Inc (NYSE: EBS) has signed a five-year agreement with Providence Therapeutics valued at about $90 million to develop and...
Via
Benzinga
Exposures
COVID-19
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
August 26, 2021
More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia...
Via
Benzinga
Exposures
COVID-19
Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment
August 25, 2021
Emergent BioSolutions Inc (NYSE: EBS) has announced the initiation of a Phase 3 trial that will evaluate its investigational SARS-CoV-2 Immune Globulin Intravenous...
Via
Benzinga
Exposures
COVID-19
Emergent BioSolutions inc (EBS) Q2 2021 Earnings Call Transcript
July 30, 2021
EBS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant
July 29, 2021
Emergent BioSolutions Inc (NYSE: EBS) will resume production of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine at its troubled Baltimore...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
These Companies Have Seen Large Returns From 2020 Government Investment
July 23, 2021
Much focus on investment comes from the private sector, particularly those of the venture capitalist persuasion. But one of the biggest investors this country has is the federal...
Via
Benzinga
FDA Releases More JNJ's COVID-19 Vaccine Substance From Baltimore Plant
July 06, 2021
Federal regulators on Friday
Via
Benzinga
Exposures
COVID-19
Product Safety
Can Emergent BioSolutions Recover From Its Recent Blunders?
July 03, 2021
Yes, but it probably won't be an easy path.
Via
The Motley Fool
Exposures
COVID-19
Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
June 29, 2021
Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-...
Via
Benzinga
Exposures
COVID-19
A Look Into Healthcare Sector Value Stocks
June 28, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
June 21, 2021
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
FDA Authorizes 10M JNJ COVID-19 Vaccine Doses, Asks To Discard 60M From Emergent Plant: NYT
June 11, 2021
The FDA has asked Johnson & Johnson (NYSE: JNJ) to discard 60 million doses of its COVID-19 vaccine manufactured at the troubled Emergent BioSolutions Inc...
Via
Benzinga
Exposures
COVID-19
Product Safety
AstraZeneca Seeks Switching COVID-19 Vaccine Production to Catalent Plant: NYT
June 03, 2021
AstraZeneca Plc (NASDAQ: AZN) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Emergent BioSolutions Inc’s (...
Via
Benzinga
Exposures
COVID-19
Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ
May 28, 2021
The FDA and Johnson & Johnson (NYSE: JNJ) are expected to announce that contamination problems at Emergent BioSolutions Inc’s (NYSE: EBS) Baltimore...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 28, 2021
Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 21.13% to $1.49 during Friday's pre-market session. The company's market cap stands at $266.9...
Via
Benzinga
Justice Department Opens Probe In Presumed lapses at Eli Lilly's COVID-19 Drug Plant: Reuters
May 27, 2021
The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (NYSE: LLY) focused on alleged manufacturing irregularities and records...
Via
Benzinga
Exposures
COVID-19
Emergent BioSolutions's Single-Dose Chikungunya Vaccine Candidate Effective Even After Two Years of Vaccination
May 26, 2021
Emergent BioSolutions Inc (NYSE: EBS) has announced two-year persistence data from its Phase 2 study evaluating its investigational chikungunya virus, virus-like...
Via
Benzinga
Emergent BioSolutions Stock Falls As Executives Face Questions As Part Of Botched Vaccine Probe
May 19, 2021
The House Select Subcommittee on the Coronavirus announced last month that they were opening an investigation into Emergent BioSolutions Inc (NYSE: EBS), with...
Via
Benzinga
Exposures
COVID-19
Cramer Weighs In On Beyond Meat, Snowflake, More
May 18, 2021
Jim Cramer said on CNBC's "Mad Money Lightning Round" he would buy more shares of Anthem Inc (NYSE: ANTM). He also likes UnitedHealth Group Inc (NYSE: UNH) and...
Via
Benzinga
Emergent Initiates Quality Enhancement Plan For Troubled Baltimore Vaccine Facility
May 12, 2021
Emergent BioSolutions Inc (NYSE: EBS) has been in headlines after its Baltimore plant has drawn the scrutiny of the FDA. A manufacturing mix-up ruined 15 million...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic
May 10, 2021
The FDA has published a roadmap for working through the backlog of facility inspections built up during the pandemic when it postponed all routine inspections in March...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2021
May 05, 2021
Upgrades Atlantic Equities upgraded the previous rating for Under Armour Inc (NYSE:UAA) from Underweight to Neutral. Under Armour earned $0.16 in the first quarter. The...
Via
Benzinga
Why Emergent BioSolutions Stock Dropped 30% in April
May 04, 2021
The company went from hero to zero in the fight against COVID-19.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub?
May 04, 2021
Shareholders beware: The hits just won't stop coming.
Via
The Motley Fool
Exposures
COVID-19
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
April 30, 2021
Emergent BioSolutions Inc has manufactured over 115 million doses of the drug substance used in the Johnson & Johnson COVID-19 vaccine, 60 million doses of which are in vials and ready to deploy at...
Via
Talk Markets
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.